Aviso:
La información contenida en éste "web site" es para uso de profesionales de la salud solamente.
Para Volver a la Página Principal
Contáctenos
Descripción
Farmacología Clínica
Indicaciones y Uso
Contraindicaciones
Advertencias
Precauciones
Reacciones Adversas
Dosificación y Administración
Presentación
Referencias

Referencias

  1. Mutchnick, M.G., et al. (1992) Thymosin: An innovative approach to the treatment of chronic hepatitis B, in Combination therapies. Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases, A.L. Goldstein and E. Garaci, Editores. Plenum Publishing Corp: New York. p. 149-156.
  2. Mutchnick, M.G., et al. (1995) Thymosin alpha 1 treatment of chronic hepatitis B: a multicenter, randomized, placebo-controlled double blind study. Gastroenterología 108(4): p. A1127.
  3. Lee, S.-D., D.-S. Chen, and Y.-F. Liaw (1997) Multicenter Study of Thymosin Alpha 1 in the Treatment of Chronic Hepatitis B. Data on file.
  4. Chien, R.-N., Liaw Y.-F., Chen, T.-C., Yeh, C.-T., and I.-S. Sheen (1998) Efficacy of Thymosin a 1 in Patients with Chronic Hepatitis B: A Randomized, Controlled Trial. Hepatology 27 (5) Mayo 1998: p.1383-1387.
  5. Niedzwiecki, D., et al. (1997) The efficacy of thymosin alpha 1 in chronic hepatitis B: a meta-analysis, Data on file.
  6. Sherman, K.E., et al. (1998) Combination Therapy with Thymosin alpha 1 and Interferon for the Treatment of Chronic Hepatitis C Infection: A Randomized, Placebo-Controlled Double-Blind Trial, Hepatology 27 (4): p.1128-1135.
  7. Rasi, G., et al. (1996) Combination thymosin a1 and lymphoblastoid interferon treatment in chronic hepatitis C, Gut 39: p. 679-683.
  8. Moscarella, S., et al. (1997) Treatment with interferon-alpha and thymosin alpha 1 of naive patients affected by chronic hepatitis C, en la 4a Reunión Internacional sobre el virus de la hepatitis C y virus relacionados. Kyoto, Japan.
  9. Sherman, K.E., et al. (1997) Pooled analysis of interferon + thymosin alpha-1 efficacy for the treatment of chronic hepatitis C. Segunda Conferencia Internacional sobre terapias para la hepatitis viral, Kona, Big Island, Hawai, Diciembre 15-19: abstract #P50.
  10. Gravenstein, S., et al. (1986) Anti-influenza antibody response: augmentation in elderly "non-responders" by thymosin alpha 1. Gerontologist 26: p. 150A.
  11. Gravenstein, S., et al. (1989) Augmentation of influenza antibody response in elderly men by thymosin alpha one. A double-blind Placebo-controlled clinical study. Journal of the American Geriatric Society 37: p. 1-8.
  12. McConnell, L. (1990) Influenza vaccine and adjuvant thymosin alpha 1. A double-blind Placebo-controlled trial. Data on file.
  13. Shen, S.Y., et al. (1990) Age-dependent enhancement of influenza vaccine responses by thymosin in chronic hemodialysis patients, in Biomedical Advances in Aging, A.L. Goldstein, Editor. Plenum Press: New York. p. 523-530.
  14. Shen, S., et al. Augmentation of specific antibody response to hepatitis vaccine with thymosin alpha 1 in chronic hemodialysis patients. University of Maryland. Data on file.
  15. Shen, S., et al. (1987) Effects of thymosin alpha 1 (TA1) on peripheral T-cell and Heptavax-B vaccination (V) in previously non-responsive hemodialysis (HD) patients (PTS). Hepatology 7(5): p. 1120.
  16. Ruggenini, A.M. Clinical experimentation for evaluation of the effect of thymosin alpha-1 in hepatitis B vaccination of unresponsive dialysis patients. Data on file.